Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing
- PMID: 32358954
- PMCID: PMC7197596
- DOI: 10.1093/cid/ciaa530
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing
Abstract
Background: To explore and describe the current literature surrounding bacterial/fungal coinfection in patients with coronavirus infection.
Methods: MEDLINE, EMBASE, and Web of Science were searched using broad-based search criteria relating to coronavirus and bacterial coinfection. Articles presenting clinical data for patients with coronavirus infection (defined as SARS-1, MERS, SARS-CoV-2, and other coronavirus) and bacterial/fungal coinfection reported in English, Mandarin, or Italian were included. Data describing bacterial/fungal coinfections, treatments, and outcomes were extracted. Secondary analysis of studies reporting antimicrobial prescribing in SARS-CoV-2 even in absence of coinfection was performed.
Results: 1007 abstracts were identified. Eighteen full texts reporting bacterial/fungal coinfection were included. Most studies did not identify or report bacterial/fungal coinfection (85/140; 61%). Nine of 18 (50%) studies reported on COVID-19, 5/18 (28%) on SARS-1, 1/18 (6%) on MERS, and 3/18 (17%) on other coronaviruses. For COVID-19, 62/806 (8%) patients were reported as experiencing bacterial/fungal coinfection during hospital admission. Secondary analysis demonstrated wide use of broad-spectrum antibacterials, despite a paucity of evidence for bacterial coinfection. On secondary analysis, 1450/2010 (72%) of patients reported received antimicrobial therapy. No antimicrobial stewardship interventions were described. For non-COVID-19 cases, bacterial/fungal coinfection was reported in 89/815 (11%) of patients. Broad-spectrum antibiotic use was reported.
Conclusions: Despite frequent prescription of broad-spectrum empirical antimicrobials in patients with coronavirus-associated respiratory infections, there is a paucity of data to support the association with respiratory bacterial/fungal coinfection. Generation of prospective evidence to support development of antimicrobial policy and appropriate stewardship interventions specific for the COVID-19 pandemic is urgently required.
Keywords: SARS-CoV-2; antimicrobial resistance; antimicrobial stewardship.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Comment in
-
Bacterial Pneumonia in COVID-19 Critically Ill Patients: A Case Series.Clin Infect Dis. 2021 Mar 1;72(5):905-906. doi: 10.1093/cid/ciaa762. Clin Infect Dis. 2021. PMID: 32544219 Free PMC article. No abstract available.
-
Reply to Dudoignon et al.Clin Infect Dis. 2021 Mar 1;72(5):906-908. doi: 10.1093/cid/ciaa767. Clin Infect Dis. 2021. PMID: 32544234 No abstract available.
-
Bacterial Coinfection in COVID-19.Clin Infect Dis. 2021 Aug 2;73(3):e843-e845. doi: 10.1093/cid/ciaa1120. Clin Infect Dis. 2021. PMID: 32761156 Free PMC article. No abstract available.
-
Painful palatal lesion in a patient with COVID-19.Oral Surg Oral Med Oral Pathol Oral Radiol. 2021 Jun;131(6):620-625. doi: 10.1016/j.oooo.2021.03.010. Epub 2021 Mar 28. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021. PMID: 33867304 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
